Peter Atadja

Peter Atadja

Director Técnico/Científico/I+D en
CommBio Therapeutics Co., Ltd.
.
66 años
Health Technology
Consumer Services

Perfil

Peter Atadja is currently the Chief Scientific Officer at CommBio Therapeutics Co., Ltd. He previously worked at Novartis Pharmaceuticals Corp.
as the Executive Director & Head-Drug Discovery from 1997 to 2021.
Additionally, he served as an Independent Director at Traws Pharma, Inc. from 2022 to 2024.
Dr. Atadja also held the position of Chief Scientific Officer at K36 Therapeutics, Inc. in the past.
He holds a doctorate degree from the University of Calgary, a graduate degree from The Hebrew University of Jerusalem, and an undergraduate degree from Kwame Nkrumah University of Science & Technology.

Cargos activos de Peter Atadja

EmpresasCargoInicio
CommBio Therapeutics Co., Ltd.
Director Técnico/Científico/I+D -

Antiguos cargos conocidos de Peter Atadja.

EmpresasCargoFin
TRAWS PHARMA, INC. Director/Miembro de la Junta 01/04/2024
Director/Miembro de la Junta 01/01/2021
Director Técnico/Científico/I+D -
Ver el detalle de la experiencia de Peter Atadja.

Formación de Peter Atadja.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

88

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

CommBio Therapeutics Co., Ltd.

Health Technology